Premium
Bimatoprost 0.03% gel for cosmetic eyelash growth and enhancement
Author(s) -
Woodward Julie A,
Haggerty Chris J,
Stinnett Sandra S,
Williams Zinaria Y
Publication year - 2010
Publication title -
journal of cosmetic dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.626
H-Index - 44
eISSN - 1473-2165
pISSN - 1473-2130
DOI - 10.1111/j.1473-2165.2010.00487.x
Subject(s) - bimatoprost , eyelash , medicine , eyelid , ophthalmology , adverse effect , intraocular pressure , latanoprost , genetics , biology
Summary Objective To evaluate a bimatoprost gel for enhancing eyelash growth, adverse effects, and change in intraocular pressure (IOP). Methods Prospective, double‐masked, randomized controlled study. Fifty‐two patients without ocular disease were assigned a control or bimatoprost 0.03% gel to apply to the eyelid margin once a day. Results The adjusted mean change in eyelash length from baseline to 6 months was 0.77 mm in the bimatoprost group and −0.12 mm in the control group ( P = 0.004). Adverse effects were experienced by 2 of 16 patients (12.5%) in the control group and 9 of 36 patients (25%) in the bimatoprost gel group. Mean change in IOP from baseline to 6 months was 0.685 mmHg in the control group and −2.04 mmHg in the bimatoprost group ( P = 0.009). Conclusions Bimatoprost gel was effective in enhancing eyelash growth. The most common adverse effect for the bimatoprost gel was conjunctival and eyelid hyperemia, while the most severe was recurrent anterior uveitis. Mean IOP was reduced in subjects using the bimatoprost gel.